187 related articles for article (PubMed ID: 10892716)
21. Cutaneous Pseudolymphoma.
Mitteldorf C; Kempf W
Surg Pathol Clin; 2017 Jun; 10(2):455-476. PubMed ID: 28477891
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous Lymphoid Hyperplasia With T-Cell Clonality and Monotypic Plasma Cells Secondary to a Tick Bite: A Hidden Critter and the Power of Deeper Levels.
Cho WC; Gill P; Nagarajan P; Aung PP; Torres-Cabala CA; Curry JL; Ivan D; Lester L; Prieto VG
Am J Dermatopathol; 2022 Mar; 44(3):226-229. PubMed ID: 35050559
[TBL] [Abstract][Full Text] [Related]
23. Drug-induced reversible lymphoid dyscrasia: a clonal lymphomatoid dermatitis of memory and activated T cells.
Magro CM; Crowson AN; Kovatich AJ; Burns F
Hum Pathol; 2003 Feb; 34(2):119-29. PubMed ID: 12612879
[TBL] [Abstract][Full Text] [Related]
24. Differential diagnosis of malignant and benign cutaneous lymphoid infiltrates: a study of 57 cases in which malignant lymphoma had been diagnosed or suspected in the skin.
Evans HL; Winkelmann RK; Banks PM
Cancer; 1979 Aug; 44(2):699-717. PubMed ID: 582573
[TBL] [Abstract][Full Text] [Related]
25. Assessment of clonality in cutaneous lymphoid infiltrates by polymerase chain reaction analysis of immunoglobulin heavy chain gene rearrangement.
Ritter JH; Wick MR; Adesokan PN; Fitzgibbon JF; Zhu X; Humphrey PA
Am J Clin Pathol; 1997 Jul; 108(1):60-8. PubMed ID: 9208979
[TBL] [Abstract][Full Text] [Related]
26. T-cell-predominant lymphoid hyperplasia in a tattoo.
Souza ES; Rocha Bde O; Batista Eda S; Oliveira RF; Farre L; Bittencourt AL
An Bras Dermatol; 2014; 89(6):1019-21. PubMed ID: 25387518
[TBL] [Abstract][Full Text] [Related]
27. Treatment of cutaneous lymphoid hyperplasia with the monoclonal anti-CD20 antibody rituximab.
Martin SJ; Duvic M
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):286-8. PubMed ID: 21658657
[TBL] [Abstract][Full Text] [Related]
28. Localized lymphoid hyperplasia of the rectum resembling polypoid mucosa-associated lymphoid tissue lymphoma: a report of three cases.
Kojima M; Itoh H; Motegi A; Sakata N; Masawa N
Pathol Res Pract; 2005; 201(11):757-61. PubMed ID: 16325519
[TBL] [Abstract][Full Text] [Related]
29. Jessner's lymphocytic infiltration of the skin: a CD8+ polyclonal reactive skin condition.
Poenitz N; Dippel E; Klemke CD; Qadoumi M; Goerdt S
Dermatology; 2003; 207(3):276-84. PubMed ID: 14571070
[TBL] [Abstract][Full Text] [Related]
30. Immunophenotypic and genotypic analysis in cutaneous lymphoid hyperplasias.
Hammer E; Sangueza O; Suwanjindar P; White CR; Braziel RM
J Am Acad Dermatol; 1993 Mar; 28(3):426-33. PubMed ID: 8445059
[TBL] [Abstract][Full Text] [Related]
31. [Pseudolymphoma of the skin: ambiguous terminology: a survey among dermatologists and pathologists].
Levy E; Godet J; Cribier B; Lipsker D
Ann Dermatol Venereol; 2013 Feb; 140(2):105-11. PubMed ID: 23395491
[TBL] [Abstract][Full Text] [Related]
32. Varicella-zoster-virus folliculitis promoted clonal cutaneous lymphoid hyperplasia.
Aram G; Rohwedder A; Nazeer T; Shoss R; Fisher A; Carlson JA
Am J Dermatopathol; 2005 Oct; 27(5):411-7. PubMed ID: 16148411
[TBL] [Abstract][Full Text] [Related]
33. Features of tattoo-associated cutaneous lymphoid hyperplasia on reflectance confocal microscopy and line-field confocal optical coherence tomography.
Ariasi C; Licata G; Perazzolli G; Tonon F; Venturini M; Calzavara-Pinton PG; Soglia S
Australas J Dermatol; 2024 May; 65(3):e50-e55. PubMed ID: 38439201
[TBL] [Abstract][Full Text] [Related]
34. Differential NFATc1 Expression in Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoma and Other Forms of Cutaneous T-Cell Lymphoma and Pseudolymphoma.
Magro CM; Momtahen S
Am J Dermatopathol; 2017 Feb; 39(2):95-103. PubMed ID: 27097342
[TBL] [Abstract][Full Text] [Related]
35. Drugs with antihistaminic properties as a cause of atypical cutaneous lymphoid hyperplasia.
Magro CM; Crowson AN
J Am Acad Dermatol; 1995 Mar; 32(3):419-28. PubMed ID: 7868710
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical profile of lymphoid lesions of the orbit.
Lowen MS; Saraiva VS; Martins MC; Burnier MN
Can J Ophthalmol; 2005 Oct; 40(5):634-9. PubMed ID: 16391631
[TBL] [Abstract][Full Text] [Related]
37. Guess what! Cutaneous lymphoid hyperplasia.
Gambichler T; Kreuter JA; Stücker M; Kobyletzki GV; Altmeyer P; Hoffmann K
Eur J Dermatol; 2000 Dec; 10(8):635-6. PubMed ID: 11125331
[No Abstract] [Full Text] [Related]
38. Treatment of Cutaneous Pseudolymphoma: A Systematic Review.
Miguel D; Peckruhn M; Elsner P
Acta Derm Venereol; 2018 Mar; 98(3):310-317. PubMed ID: 29136262
[TBL] [Abstract][Full Text] [Related]
39. Drug-induced immune dysregulation as a cause of atypical cutaneous lymphoid infiltrates: a hypothesis.
Magro CM; Crowson AN
Hum Pathol; 1996 Feb; 27(2):125-32. PubMed ID: 8617453
[TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
